Type 2 Diabetes 2017 Global Market Expected to Grow at CAGR 7.28% and Forecast to 2020

WiseGuyReports.Com Publish a New Market Research Report On - “Type 2 Diabetes 2017 Global Market Expected to Grow at CAGR 7.28% and Forecast to 2020”.


New York, NY -- (SBWIRE) -- 06/26/2017 -- The analysts forecast the global type 2 diabetes drugs market to grow at a CAGR of 7.28% during the period 2016-2020.

Diabetes, often referred to as diabetes mellitus, is a metabolic disease in which the patients' blood glucose levels remains high. Depending on the cause of development of diabetes, it can be divided into three types:

- Type 1 diabetes (or insulin-dependent diabetes mellitus): In this condition, the pancreas do not produce the required amount of insulin, leading to high blood glucose levels.

- Type 2 diabetes (non-insulin dependent diabetes mellitus): In this condition, though the body produces the required amount of insulin, the cells do not respond to it, increasing the glucose levels in the body.

- Gestational diabetes: This condition occurs in pregnant women without any prior history of diabetes

Type 2 diabetes, also known as adult-onset diabetes, is a result of the body's inability to produce enough insulin or insulin resistance or both. It is managed by providing symptomatic relief and improving the quality of life. Type 2 diabetes accounts for nearly 90%-95% of the total number of diabetes cases worldwide and is primarily diagnosed in the middle-aged and old age groups, i.e., between the ages of 30 and 75 years. However, it can occur even during childhood. The risks of type 2 diabetes include high blood pressure, advancing age, obesity, history of gestational diabetes, family history of diabetes, poor nutrition during pregnancy, physical inactivity, and impaired glucose tolerance.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/375050-global-type-2-diabetes-market-2016-2020

For more information or any query mail at sales@wiseguyreports.com

Covered in this report

The report covers the present scenario and the growth prospects of the global type 2 diabetes drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat type 2 diabetes.

The market is divided into the following segments based on geography:
- Americas

The report, Global Type 2 Diabetes Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AstraZeneca plc
- Eli Lilly and Company
- Merck & Co. Inc.
- Novo Nordisk A/S
- Sanofi SA

Other prominent vendors
- Adocia
- Akros Pharma
- Amgen
- Astellas Pharma
- Biocon
- Boehringer Ingelheim
- Chipscreen Biosciences
- ConjuChem
- CymaBay Therapeutics
- Daiichi Sankyo
- DiaMedica
- Diasome Pharmaceuticals
- Dong-A ST
- Elcelyx Therapeutics
- Exsulin
- Generex
- Genfit
- Hanmi
- Hua Medicine
- InteKrin Therapeutics
- Ionis Pharmaceuticals
- Janssen Pharmaceuticals
- Japan Tobacco
- Kadmon
- KinDex Pharmaceuticals
- Kissei
- Kotobuki Pharmaceutical
- Lexicon Pharmaceuticals
- Ligand
- MannKind
- MedImmune
- Melior Pharmaceuticals
- Metabolic Solutions Development Company
- Mitsubishi Tanabe Pharma
- Novartis
- NGM Bio
- NuSirt Biopharma
- Oramed
- Peptron
- Pfizer
- PhaseBio
- Poxel
- Sanwa Kagaku Kenkyusho
- Sirona Biochem
- Takeda
- Theracos
- Theratechnologies
- Transition Therapeutics
- VeroScience
- vTv Therapeutics
- XBiotech

Market driver
- Rising prevalence of diabetes
- For a full, detailed list, view our report

Market challenge
- Low diagnosis rate
- For a full, detailed list, view our report

Market trend
- Increase in awareness of diabetes
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/375050-global-type-2-diabetes-market-2016-2020

Table Of Contents – Major Key Points

PART 01: Executive summary
- Highlights

PART 02: Scope of the report
- Market overview
- Top-vendor offerings

PART 03: Market research methodology
- Research methodology
- Economic indicators

PART 04: Introduction
- Key market highlights
- Key buying criteria

PART 05: Disease overview
- Introduction
- Risk factors
- Diagnosis
- Management
- Epidemiology
- Economic burden

PART 06: Pipeline portfolio

PART 07: Market landscape
- Global diabetes drugs market
- Global type 2 diabetes drugs market
- Five forces analysis

PART 08: Market segmentation by drug class

PART 09: Insulin
- Product portfolio
- Global insulin market

PART 10: DPP-4 inhibitors
- Market overview
- Market size and forecast


For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=375050

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.